Overview
Dr. Pavlisko holds an undergraduate degree in Biochemistry from Clemson University and received her Doctor of Medicine from the Medical University of South Carolina. She completed her residency and is board certified in both Anatomic and Clinical Pathology. She trained as a pulmonary/thoracic pathology fellow at Duke University Medical Center under the mentorship of Drs. Victor Roggli and Thomas Sporn, two of the world’s leading Pulmonary Pathologist with expertise in pneumoconiosis and mesothelioma. She joined the faculty at Duke in 2011 as an Assistant Professor of Pathology, and her work is focused in thoracic, cardiovascular and transplant pathology as well as postmortem examination. Since starting her independent position, Dr. Pavlisko has developed expertise in neoplastic and non-neoplastic diseases of the lung and mediastinum with a special interest in lung transplantation and diseases of the pleura for which she is widely recognized as an authority. She currently serves as Chief of the Pulmonary/Thoracic Pathology Section.
Dr. Pavlisko’s clinical activities encompass pulmonary/thoracic and cardiovascular pathology, including transplantation, biomarker testing and autopsy pathology. Her primary research focus has centered on malignant mesothelioma and chronic lung allograft dysfunction (CLAD). She has published over 65 manuscripts and has 6 book chapters, the latter all centered on occupational diseases of the lungs and pleura. Since 2017, Dr. Pavlisko has co-chaired the lung steering committee for the Banff Foundation for Allograft Pathology. She is also an active member of the International Society for Heart and Lung Transplantation. Dr. Pavlisko has collaborations with the Departments of Pulmonary, Allergy and Critical Care Medicine and Cardiothoracic Surgery.
In addition to her clinical and research activities, Dr. Pavlisko is active in Duke University Hospital’s Clinical Laboratories and currently serves as the Medical Director of the Division of Anatomic Pathology and Digital Analytics (DAPDA) Laboratory, which includes Histology, Immunohistochemistry, FISH, and Image Analysis.
Current Appointments & Affiliations
Recent Publications
Pathologists' experience and routine practice in high-volume lung transplant centers: An international survey.
Journal Article JHLT Open · February 2026 Lung allograft pathology encompasses a wide spectrum of disorders, with new entities and emerging diagnostic technologies. The main goal of this study was to document pathologists' current global practices and highlight areas of consensus and divergence wo ... Full text Link to item CiteConsiderations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement.
Journal Article J Heart Lung Transplant · November 14, 2025 Clinical trials in lung transplantation have been hindered by a lack of clarity on the formulation and significance of endpoints for evaluating therapeutic efficacy. To address this challenge, a multidisciplinary working group from the International Societ ... Full text Link to item CiteAutomation of fluorescent in situ hybridization (FISH) leading to cost savings and consistent high-quality results.
Journal Article J Clin Pathol · September 17, 2025 AIMS: Despite continually improving guidelines, human epidermal growth factor receptor 2 (HER2) testing for breast and gastro-oesophageal carcinoma continues to be a technical challenge in clinical laboratories. Manual HER2 fluorescence in situ hybridisati ... Full text Link to item CiteRecent Grants
Lung Transplant Clinical Trial Network (LT-CTN)
ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2028CXCR2 expression in lung neuroendocrine neoplasms
ResearchMentor · Awarded by Lung Cancer Initiative of North Carolina · 2024 - 2025CTOT Long-Term Extension Study
ResearchPathologist · Awarded by Cystic Fibrosis Foundation · 2019 - 2024View All Grants